Free Trial
NASDAQ:MTSR

Metsera (MTSR) Stock Price, News & Analysis

Metsera logo
$34.89 +1.90 (+5.76%)
As of 08/1/2025 04:00 PM Eastern

About Metsera Stock (NASDAQ:MTSR)

Key Stats

Today's Range
$31.01
$35.15
50-Day Range
$25.38
$44.30
52-Week Range
$12.30
$47.40
Volume
2.06 million shs
Average Volume
1.03 million shs
Market Capitalization
$3.67 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$55.00
Consensus Rating
Buy

Company Overview

Receive MTSR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Metsera and its competitors with MarketBeat's FREE daily newsletter.

MTSR Stock News Headlines

Metsera FY2025 EPS Forecast Reduced by Cantor Fitzgerald
He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.
See More Headlines

MTSR Stock Analysis - Frequently Asked Questions

Metsera's stock was trading at $29.50 on January 1st, 2025. Since then, MTSR shares have increased by 18.3% and is now trading at $34.89.

Metsera Inc. (NASDAQ:MTSR) released its earnings results on Monday, July, 28th. The company reported ($0.66) EPS for the quarter.

Metsera (MTSR) raised $275 million in an initial public offering (IPO) on Friday, January 31st 2025. The company issued 15,277,778 shares at $18.00 per share.

Metsera's lock-up period expired on Wednesday, July 30th. Metsera had issued 15,277,778 shares in its initial public offering on January 31st. The total size of the offering was $275,000,004 based on an initial share price of $18.00. Since the expiration of the company's lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company have been lifted.

Top institutional investors of Metsera include Jennison Associates LLC (0.30%), Exchange Traded Concepts LLC (0.04%), TD Asset Management Inc (0.04%) and KLP Kapitalforvaltning AS.

Shares of MTSR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
7/28/2025
Today
8/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MTSR
Previous Symbol
NASDAQ:MTSR
CIK
2040807
Web
N/A
Fax
N/A
Employees
81
Year Founded
N/A

Price Target and Rating

High Price Target
$65.00
Low Price Target
$38.00
Potential Upside/Downside
+57.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.26
Quick Ratio
6.55

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.28 per share
Price / Book
8.15

Miscellaneous

Outstanding Shares
105,060,000
Free Float
N/A
Market Cap
$3.67 billion
Optionable
N/A
Beta
N/A

Social Links

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:MTSR) was last updated on 8/3/2025 by MarketBeat.com Staff
From Our Partners